These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 33853959)

  • 1. Prazoles Targeting Tsg101 Inhibit Release of Epstein-Barr Virus following Reactivation from Latency.
    Mannemuddhu SS; Xu H; Bleck CKE; Tjandra N; Carter C; Bhaduri-McIntosh S
    J Virol; 2021 Jun; 95(13):e0246620. PubMed ID: 33853959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Mechanism-Based Targeted Screen To Identify Epstein-Barr Virus-Directed Antiviral Agents.
    Li X; Akinyemi IA; You JK; Rezaei MA; Li C; McIntosh MT; Del Poeta M; Bhaduri-McIntosh S
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32796077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective Targeting of Virus Replication by Proton Pump Inhibitors.
    Watanabe SM; Ehrlich LS; Strickland M; Li X; Soloveva V; Goff AJ; Stauft CB; Bhaduri-McIntosh S; Tjandra N; Carter C
    Sci Rep; 2020 Mar; 10(1):4003. PubMed ID: 32132561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the TSG101 gene in Epstein-Barr virus late gene transcription.
    Chua HH; Lee HH; Chang SS; Lu CC; Yeh TH; Hsu TY; Cheng TH; Cheng JT; Chen MR; Tsai CH
    J Virol; 2007 Mar; 81(5):2459-71. PubMed ID: 17182691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipyridamole as a new drug to prevent Epstein-Barr virus reactivation.
    Thomé MP; Borde C; Larsen AK; Henriques JAP; Lenz G; Escargueil AE; Maréchal V
    Antiviral Res; 2019 Dec; 172():104615. PubMed ID: 31580916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spironolactone blocks Epstein-Barr virus production by inhibiting EBV SM protein function.
    Verma D; Thompson J; Swaminathan S
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3609-14. PubMed ID: 26976570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr Virus Enhances Cancer-Specific Aberrant Splicing of TSG101 Pre-mRNA.
    Chua HH; Kameyama T; Mayeda A; Yeh TH
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus.
    Gorres KL; Daigle D; Mohanram S; McInerney GE; Lyons DE; Miller G
    mBio; 2016 Mar; 7(2):e00113. PubMed ID: 26933051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic Activation of Lytic Epstein-Barr Virus Gene Expression without Virion Production.
    Lee J; Kosowicz JG; Hayward SD; Desai P; Stone J; Lee JM; Liu JO; Ambinder RF
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31341058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)- induced lymphoproliferative disease and lytic viral replication.
    Bilger A; Plowshay J; Ma S; Nawandar D; Barlow EA; Romero-Masters JC; Bristol JA; Li Z; Tsai MH; Delecluse HJ; Kenney SC
    Oncotarget; 2017 Jul; 8(27):44266-44280. PubMed ID: 28574826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
    Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
    Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation.
    Zhang Y; Jiang C; Trudeau SJ; Narita Y; Zhao B; Teng M; Guo R; Gewurz BE
    mBio; 2020 Oct; 11(5):. PubMed ID: 33109754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent Inhibition of Hepatitis E Virus Release by a Cyclic Peptide Inhibitor of the Interaction between Viral Open Reading Frame 3 Protein and Host Tumor Susceptibility Gene 101.
    Anang S; Kaushik N; Hingane S; Kumari A; Gupta J; Asthana S; Shalimar ; Nayak B; Ranjith-Kumar CT; Surjit M
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Niclosamide inhibits lytic replication of Epstein-Barr virus by disrupting mTOR activation.
    Huang L; Yang M; Yuan Y; Li X; Kuang E
    Antiviral Res; 2017 Feb; 138():68-78. PubMed ID: 27939840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFI16 Partners with KAP1 to Maintain Epstein-Barr Virus Latency.
    Xu H; Li X; Rousseau BA; Akinyemi IA; Frey TR; Zhou K; Droske LE; Mitchell JA; McIntosh MT; Bhaduri-McIntosh S
    J Virol; 2022 Sep; 96(17):e0102822. PubMed ID: 35969079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenofovir prodrugs potently inhibit Epstein-Barr virus lytic DNA replication by targeting the viral DNA polymerase.
    Drosu NC; Edelman ER; Housman DE
    Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12368-12374. PubMed ID: 32409608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin conjugation to Gag is essential for ESCRT-mediated HIV-1 budding.
    Sette P; Nagashima K; Piper RC; Bouamr F
    Retrovirology; 2013 Jul; 10():79. PubMed ID: 23895345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Epstein-Barr virus reactivation in nasopharyngeal carcinoma cells by dietary sulforaphane.
    Wu CC; Chuang HY; Lin CY; Chen YJ; Tsai WH; Fang CY; Huang SY; Chuang FY; Lin SF; Chang Y; Chen JY
    Mol Carcinog; 2013 Dec; 52(12):946-58. PubMed ID: 22641235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luteolin inhibits Epstein-Barr virus lytic reactivation by repressing the promoter activities of immediate-early genes.
    Wu CC; Fang CY; Hsu HY; Chen YJ; Chou SP; Huang SY; Cheng YJ; Lin SF; Chang Y; Tsai CH; Chen JY
    Antiviral Res; 2016 Aug; 132():99-110. PubMed ID: 27185626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors.
    Kerr JR
    J Clin Pathol; 2019 Oct; 72(10):651-658. PubMed ID: 31315893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.